European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)

Submitted by Anonymous (not verified) on 27 May 2026 - 15:12

European Medicines Agency (EMA) / European Chemicals Agency (ECHA) joint meeting with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 June 2026, 09:00 (CEST) to 9 June 2026, 12:00 (CEST)

Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised

Submitted by Anonymous (not verified) on 27 May 2026 - 14:40

Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 27 May 2026 - 14:25

Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 3, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More